Onconetix (ONCO)

• Market cap: $4.43M
• 1 day: -15.93%
• 5 days: -19.03%
• 1 month: -8.65%
• 3 months: -10.09%
• 6 months: -52.26%
• Year to date: -94.85%
• 1 year: -98.84%
• 5 years: -100%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

Employees: 5